Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 August 2019 | Story Lacea Loader

The composition of the UFS Council is stipulated in the UFS Statute, which was published in the Government Gazette on 26 January 2018 and amended by publication in the Government Gazette on 29 March 2019.

The Convocation has to elect two (2) external (neither employees nor students of UFS) representatives to the Council to represent the Convocation and Alumni on Council, following the expiry of the term of office of these representatives.  The two (2) elected representatives will serve for a period of four years on Council.

The Convocation comprises all persons who obtained a formal qualification from the UFS, as well as all permanent academic staff members.

Members of the Convocation are invited to submit written nominations by using the Nomination Form, for the following:

1.    one representative from the Qwaqwa Campus; and
2.    one other representative.

Every nomination form shall be signed by 4 (four) members of the Convocation and shall contain the written acceptance of the nomination by the nominee under his/her signature, as well as an abridged CV and a motivation of ± 200 words.

All nominations must reach the office of the Registrar no later than 16:30 on Tuesday, 17 September 2019.

If more than one person is nominated for each of the categories mentioned above, elections will be held as stipulated in the Institutional Rules. More information regarding this process will follow at that stage.

Nominations are to be submitted to:
e-mail: registrar@ufs.ac.za

or by post (strongly advised not to use this method due to delays):

Mr NN Ntsababa  
Registrar
University of the Free State
PO Box 339
Bloemfontein
9300

or hand-delivered to:                

Mr NN Ntsababa
Room 51, 1st Floor
Main Building
UFS Bloemfontein Campus

For enquiries, please contact Mr NN Ntsababa at registrar@ufs.ac.za or +27 51 401 3796.

Kindly take note that late or incomplete nominations will not be accepted or considered.

Every nomination must be submitted separately.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept